Course Hero Logo

ETHICAL ISSUES IN A CORPORATE CASE-1155103.docx - Ethical...

Course Hero uses AI to attempt to automatically extract content from documents to surface to you and others so you can study better, e.g., in search results, to enrich docs, and more. This preview shows page 1 - 4 out of 6 pages.

Ethical Issues In a Corporate Case 1ETHICAL ISSUES IN A CORPORATE CASE(Turin Pharmaceuticals)by Student’s NameCode + Course NameProfessor’s NameUniversity NameCity, StateDate
Ethical Issues In a Corporate Case 2Table of ContentsCompany Background……………………………………………………………………………………………………………….………..3Ethical Issues………………………………………………………………………………………………………………………………………4Stakeholders Impacted by the Ethical Issues……………………………………………………………………………..………4Was the decision made Ethical?.............................................................................................................5Business Ethics.........................................................................................................................................6References..............................................................................................................................................6
Ethical Issues In a Corporate Case 31.Company backgroundTuring Pharmaceuticals Company is an incorporated pharmaceutical company with itsheadquarters in New York City. It was founded by Mark Shkreli in 2014 and started in February2015, and has an employee base of between 51 and 100 (Crunchbase, 2018), it capitalized in twomarketed products which are Daraprim which is used to treat toxoplasmosis, and Vecamyl usedin treating hypertension. Upon its foundation, Turing Pharmaceuticals acquired Daraprim in thefirst five operational months, it bought the sole rights to own and sell the drug in both the UnitedStates and Puerto Rico and set up research plants to carry out research programs onToxoplasmosis which is the disease to be treated by Daraprim. The attention of Turinpharmaceuticals to research on Toxoplasmosis by the fact that all recent researches carried outfor a period extending behind 50 years had not resolved its problem which saw it being listed byCentre for Disease Control as one of the 5 globally neglected parasitic infections (Background onTuring Pharmaceuticals, 2016). Turing came out to improve the accessibility of treatment for thepatients suffering from the disease and to at the same time come up with diverse treatmentoptions. It conducts its research in the United States and around the globe.

Upload your study docs or become a

Course Hero member to access this document

Upload your study docs or become a

Course Hero member to access this document

End of preview. Want to read all 6 pages?

Upload your study docs or become a

Course Hero member to access this document

Term
Fall
Professor
N/A
Tags
Business Ethics, Turing Pharmaceuticals

Newly uploaded documents

Show More

Newly uploaded documents

Show More

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture